Cargando…
Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience.
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299847/ https://www.ncbi.nlm.nih.gov/pubmed/37399601 http://dx.doi.org/10.1016/j.retram.2023.103402 |
| _version_ | 1785064457545711616 |
|---|---|
| author | Xue, Elisabetta Scorpio, Gianluca Ruggeri, Annalisa Clerici, Daniela Farina, Francesca Campodonico, Edoardo Acerbis, Andrea Fiore, Paolo Bruno, Alessandro Carrabba, Matteo G Peccatori, Jacopo Greco, Raffaella Stanghellini, Maria Teresa Lupo Ciceri, Fabio Corti, Consuelo |
| author_facet | Xue, Elisabetta Scorpio, Gianluca Ruggeri, Annalisa Clerici, Daniela Farina, Francesca Campodonico, Edoardo Acerbis, Andrea Fiore, Paolo Bruno, Alessandro Carrabba, Matteo G Peccatori, Jacopo Greco, Raffaella Stanghellini, Maria Teresa Lupo Ciceri, Fabio Corti, Consuelo |
| author_sort | Xue, Elisabetta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10299847 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102998472023-06-28 Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience. Xue, Elisabetta Scorpio, Gianluca Ruggeri, Annalisa Clerici, Daniela Farina, Francesca Campodonico, Edoardo Acerbis, Andrea Fiore, Paolo Bruno, Alessandro Carrabba, Matteo G Peccatori, Jacopo Greco, Raffaella Stanghellini, Maria Teresa Lupo Ciceri, Fabio Corti, Consuelo Curr Res Transl Med Letter to the Editor Elsevier Masson SAS. 2023-06-28 /pmc/articles/PMC10299847/ /pubmed/37399601 http://dx.doi.org/10.1016/j.retram.2023.103402 Text en © 2023 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Xue, Elisabetta Scorpio, Gianluca Ruggeri, Annalisa Clerici, Daniela Farina, Francesca Campodonico, Edoardo Acerbis, Andrea Fiore, Paolo Bruno, Alessandro Carrabba, Matteo G Peccatori, Jacopo Greco, Raffaella Stanghellini, Maria Teresa Lupo Ciceri, Fabio Corti, Consuelo Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience. |
| title | Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience. |
| title_full | Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience. |
| title_fullStr | Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience. |
| title_full_unstemmed | Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience. |
| title_short | Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience. |
| title_sort | impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and car t-cell therapy: a single center experience. |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299847/ https://www.ncbi.nlm.nih.gov/pubmed/37399601 http://dx.doi.org/10.1016/j.retram.2023.103402 |
| work_keys_str_mv | AT xueelisabetta impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT scorpiogianluca impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT ruggeriannalisa impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT clericidaniela impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT farinafrancesca impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT campodonicoedoardo impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT acerbisandrea impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT fiorepaolo impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT brunoalessandro impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT carrabbamatteog impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT peccatorijacopo impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT grecoraffaella impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT stanghellinimariateresalupo impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT cicerifabio impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience AT corticonsuelo impactoftixagevimabcilgavimabprophylaxisinpatientsundergoingallogeneichematopoieticstemcelltransplantsandcartcelltherapyasinglecenterexperience |